Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for PBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 -37.23M
March 31, 2024 -38.13M
December 31, 2023 -32.75M
September 30, 2023 -28.60M
June 30, 2023 -25.12M
March 31, 2023 -32.45M
December 31, 2022 -32.69M
September 30, 2022 -29.78M
June 30, 2022 -27.21M
March 31, 2022 -24.75M
December 31, 2021 -22.21M
September 30, 2021 -19.98M
June 30, 2021 -22.30M
March 31, 2021 -20.53M
December 31, 2020 -16.92M
September 30, 2020 -14.54M
June 30, 2020 -14.21M
March 31, 2020 -13.66M
December 31, 2019 -12.06M
September 30, 2019 -9.624M
June 30, 2019 -8.182M
March 31, 2019 -6.773M
December 31, 2018 -6.125M
September 30, 2018 -5.219M
June 30, 2018 -4.744M
Date Value
March 31, 2018 -16.48M
December 31, 2017 -14.62M
September 30, 2017 -12.65M
June 30, 2017 -13.11M
March 31, 2017 -13.46M
December 31, 2016 -8.383M
September 30, 2016 -12.76M
June 30, 2016 -12.43M
March 31, 2016 -13.86M
December 31, 2015 -7.978M
September 30, 2015 -4.492M
June 30, 2015 -4.329M
March 31, 2015 -3.223M
December 31, 2014 -2.060M
September 30, 2014 -2.078M
June 30, 2014 -1.271M
March 31, 2014 -1.241M
December 31, 2013 -1.968M
September 30, 2013 -1.674M
June 30, 2013 -1.219M
March 31, 2013 -0.402M
December 31, 2012 -1.540M
September 30, 2012 -0.7308M
June 30, 2012 -0.812M
March 31, 2012 -0.6358M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 7.363B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B
Danaher Corp. 52.58B
Harvard Bioscience, Inc. 7.418M